Neurology® Podcast

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. William S. David and Dr. Steven M. Albert interview Dr. Vincent Meininger, Professor of Neurology at the Saltpetriere in Paris, France about his paper on amyotrophic lateral sclerosis. The podcast concludes with Dr. Richard Leigh interviewing Dr. John Carew for the Lesson of the Week. The participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Michael Benatar and Dr. Beth Lang interview Dr. Francesc Graus from the Hospital Clinic in Barcelona, Spain about his paper on SOX1 antibodies. The podcast concludes with Dr. Harman Bajwa interviewing Dr. Josep Dalmau for Lesson of the Week. Podcast participants had nothing to disclose except for Dr. Dalmau. He has given 1 or 2 talks per year that are sponsored by Athena Diagnostics.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Aman A. Savani and Dr. Thomas Wingo interview Dr. Donald H. Gilden from the University of Colorado about his paper on VZV vasculopathy. The podcast concludes with Dr. Michael Brooke introducing the Humanities section of the journal and then reading three poems by Nina F. Schor published in January 22, 2008 issue. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Justin Sattin and Dr. Kinan K. Hreib interview Dr. Paul Surtees from the University of Cambridge about his paper on depressive disorder and risk of stroke. The podcast concludes with Dr. Robert Hoesch interviewing Dr. Anna Ledegza for Lesson on the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Ryan Overman and Dr. Greg Schaublin interview Dr. Paul Brown,recently retired from the National Institutes of Health in Bethesda, MD. The podcast concludes with Dr. Jason Mackey interviewing Dr. Chum Lim for Lesson of the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Beau Bruce and Dr. Jeremy Lanford interview Dr. Michael Wall from the University of Iowa about his paper on intracranial hypertension. The podcast concludes with Dr. Shanna Patterson interviewing Dr. Virgilio Evidente for Lesson on the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jennifer Bickel and Dr. Rob Armstrong interview Dr. Kathleen Merikangas from the NIH about her paper on the topic of headache-related disability. The podcast concludes with Dr. Sam Ghaffari interviewing Dr. Stephanie Studenski for Lesson on the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. John Morgan and Dr. Shanna Patterson interview Dr. David J. Thurman from CDC National Center in Atlanta, GA about his practice parameter on the topic of risk of falls. The podcast concludes with Dr. David Polston interviewing Dr. Robert Holloway for Lesson on the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Michael Levy and Dr. Chris Inglese interview Dr. Sean Pittock & Dr. Brenda Banwell about their paper on childhood inflammatory demyelinating CNS disorders. The podcast concludes with Dr. Lee Dresser interviewing Dr. Mark Mullins for Lesson of the week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Laura Tormoehlen interviews Dr. Michael Williams for the Lesson of the week. The podcast concludes with Dr. Jim Bernat and Dr. Dan Larriviere interviewing Dr. David Greer from the Massachusetts General Hospital about his paper about AAN brain death guidelines. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Juliana Lockman and Dr. Matt Stead interview Dr. Raj Sheth from the University of Wisconsin about his paper on bone loss in children with epilepsy. The podcast concludes with Dr. Nick Silvestri interviewing Dr. Vin Tangpricha for the Lesson of the week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Roland More and Dr. Morie Gertz interview Dr. Taro Yamashita from Kumamoto University in Japan about his paper on the effects of liver transplantation on transthyretin Tyr114Cys-related cerebral amyloid angiopathy. The podcast concludes with Dr. Farrah Mateen interviewing Dr. Donald Mulder for our first Historical interview. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Jaideep Kapur and Dr. Ty Schwertfeger interview Dr. Yitzhak Schiller from Rambam Medical Center, Haifa Israel about his paper on the topic of drug resistance in epilepsy. The podcast concludes with Dr. Crystal Richards interviewing Dr. Robert M. Hoekstra for Lesson on the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Merit E. Cudkowicz and Dr. Branavan Mahadeva interview Dr. Mustafa Hammad from Emory University about his paper on sensory abnormalities in ALS. The podcast concludes with our first Clinical Pearl interview where Dr. Ryan Overman interviews Dr. Janet Rucker. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. John Mytinger and Dr. Bennett Shaywitz interview Dr. Bernard Chang from Harvard Medcial School about his paper on genetic brain malformation. The podcast concludes with Dr. Ted Burns interviewing Martha Barnette for Lesson of the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. John Hardy and Dr. Demetrius M. Maraganore interview Dr. Christine Klein from University of Lubeck in Germany and Dr. Michael Schossmacher from University of Ottawa about their paper on alpha-synuclein ten years later. The podcast concludes with Dr. Bryan Traynor interviewing Dr. Sonja Scholz for the Lesson of the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. John Croom and Dr. Jonathan Marcus interview Dr. Allan Krumholz from the University of Maryland and Dr. Gary Gronseth from the University of Kansas about their practice parameter on unprovoked first seizure in adults. The podcast concludes with Dr. Adam Heller interviewing Dr. Gary Gronseth for the Lesson of the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Brad Worrall & Dr. Bernadette Boden-Albala interview Dr. Amytis Towfighi from University of California at Los Angeles about her paper on midlife stroke surge among women in the U. S. The podcast concludes with Dr. Justin Sattin interviewing Dr. Kathryn S. Porter for the Lesson of the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Howard Hurtig and Dr. David A. Schoenfeld interview Dr. Beate Ritz from UCLA about her paper on nonsteroidal anti-inflammatory drugs. The podcast concludes with Dr. Lee I. Kubersky interviewing Dr. Carmel Armon for the Lesson of the Week. Podcast participants had nothing to disclose.

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief, briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Blaise Bourgeois & Dr. Nathan Fountain interview Dr. Samuel Berkovic from the Epilepsy Research Center University of Melbourne, Australia about his paper studying the use of levetiracetam in patients with idiopathic generalized epilepsy. The podcast concludes with Dr. Andrew Tarulli interviewing Dr. Michael J. Lynn for the Lesson of the Week. Podcast participants had nothing to disclose except for Drs. Berkovic and Bourgeois. Dr. Berkovic has received grants in excess of $10,000 and honoraria not in excess of $10,000 from UCB Pharma SA, who were involved in the design and conduct of the study; collection, management, and analysis of the data; and preparation and review of the manuscript. Dr. Bourgeois has received grant support or consulting fees from Abbott, Eisai, Elan Pharmaceuticals, Ortho-McNeil, Novartis, Ovat